Kezar Life Sciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -176 | -227 | |
EBITDA | -8,151 | -10,462 | -13,159 |
EBIT | -8,327 | -10,689 | -13,402 |
Net Income | -14,546 | -11,227 | -13,704 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -11,962 | -9,830 | -12,795 |
Cash | 71,878 | 38,935 | 34,367 |
Basic Shares | 7,316 | 7,323 | 7,311 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $7,000 | $0 |
Gross Profit | -897 | -1,040 | 7,000 | -1,022 |
EBITDA | -51,373 | -81,103 | -99,254 | -70,139 |
EBIT | -52,270 | -82,143 | -100,320 | -71,162 |
Net Income | -56,033 | -83,736 | -101,870 | -65,316 |
Net Change In Cash | 0 | 0 | 7,000 | 0 |
Cost of Revenue | -22,377 | |||
Free Cash Flow | -51,785 | -74,241 | -83,455 | -60,424 |
Cash | 71,878 | 41,749 | 35,493 | 40,456 |
Basic Shares | 7,316 | 72,902 | 72,553 | 67,368 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.70 |
2025-12-31 | -$1.05 |
2025-09-30 | -$1.53 |
2025-06-30 | -$1.87 |